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The aim of this study was to develop an animal model with non-laying hens which would
allow for investigation of the relationship between egg production and common diseases
in hens. A total of 40 Lohmann Selected Leghorn hens were kept for 20 weeks in a floor
housing system in two groups: group “Adult” (21 weeks of age) and group “Juvenile” (14
weeks of age). In each group, 10 hens were administered a 4.7 mg sustained release
deslorelin acetate implant subcutaneously; in group “Adult” after, in group “Juvenile”
before the onset of lay. In both groups, the remaining hens served as control hens. An
examination of each hen was performed weekly, including ultrasonography to check
for ovarian follicles, analysis of estradiol-17ß plasma concentration, and assessment of
comb size. Digital radiographs of the keel bone were taken in experimental weeks 7
and 15. No follicles were detected on the ovary of treated hens for a certain time period
which varied between individuals (between 8 weeks and until the end of the experiment).
Estradiol-17ß concentrations were significantly higher in control hens. The comb was
significantly smaller in treated hens. A lower prevalence of keel bone damage (group
“Adult”) and foot pad dermatitis (FPD) (both groups) was found in treated compared
to control hens. These results show that a model with laying and non-laying hens can
be achieved by administering a deslorelin acetate implant. Furthermore, they indicate a
relationship between egg production and keel bone damage as well as FPD.
Keywords: laying hen, egg, follicle, gonadotropin-releasing hormone, deslorelin acetate, estradiol, keel bone, foot
pad dermatitis
INTRODUCTION
Laying hens often suffer from a variety of diseases such as osteoporosis (FAWC, 2010), keel bone
fractures and deviations (Fleming et al., 2004; Rodenburg et al., 2008; Käppeli et al., 2011b; Wilkins
et al., 2011; Petrik et al., 2015), and fatty liver hemorrhagic syndrome (Shini and Bryden, 2009).
The high laying performance might be a related factor to these medical conditions. Concerning
bone diseases, it is known that there is a high calcium demand for the egg shell and thus high laying
performance may lead to weaker bones (Whitehead et al., 2003; FAWC, 2010). Concerning the
fatty liver hemorrhagic syndrome, high performing hens may be more susceptible because of the
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stimulation of lipogenesis in the liver during egg production
(Butler, 1976; Aydin, 2005; Deng et al., 2012).
A promising way to investigate possible relationships between
egg production and these common diseases in laying hens as well
as the underlying mechanisms may be the comparison of laying
and non-laying hens of the same breed and age. Therefore, the
aim of the current study was to develop an animal model in
which egg production was selectively suppressed in hens to allow
comparisons of traits with laying control hens.
An agent which is often used for reproductive management in
several species is the synthetic gonadotropin-releasing hormone
(GnRH) agonist deslorelin acetate. Naturally produced GnRH
is secreted by the hypothalamus in a pulsatile manner (Carmel
et al., 1976; Tsutsumi and Webster, 2009) and acts at pituitary
receptors to induce the secretion of follicle-stimulating hormone
(FSH) and luteinizing hormone (LH) (Ottinger et al., 2002). FSH
and LH act at the gonads where they induce gametogenesis,
gonadal steroidogenesis and, in females, ovulation. In contrast
to pulsatile secretion, continuous presence of GnRH or its
agonist results in a desensitization of the GnRH receptors and,
consequently, a shutdown of the reproductive cascade (Belchetz
et al., 1978; Rabin and McNeil, 1980; Ottinger et al., 2002;
Gobello, 2007). This can be achieved by the use of slow-release
deslorelin acetate implants, for example Suprelorin R© (Virbac,
Carros, France). This implant has been developed for chemical
castration in male dogs and is available in two different strengths:
4.7 mg deslorelin acetate and 9.4 mg deslorelin acetate. In dogs,
the duration of effectiveness, i.e., the time period during which
reproductive function is suppressed, is six (4.7 mg) and twelve
(9.4 mg) months, respectively (Ponglowhapan, 2011). In pet
birds, deslorelin acetate implants are frequently used to suppress
undesired reproductive activity (Keller et al., 2013; Mans and
Pilny, 2014). In adult female cockatiels, one 4.7 mg deslorelin
acetate implant has been shown to significantly prevent egg laying
for at least 180 days (Summa et al., 2017). Investigating the effect
of deslorelin acetate on egg production in poultry, most studies
have been conducted using Japanese quail. Petritz et al. (2013)
found a complete suppression of egg production by a 4.7 mg
deslorelin acetate implant in six out of ten hens for 10 weeks.
Plasma concentration of estradiol-17ß was significantly lower
in non-laying compared to laying quail. However, the implant
did not show any effect on the laying activity in the remaining
hens (Petritz et al., 2013). In a subsequent study, the authors
found seven out of ten Japanese quail without oviposition in
two treatment groups: one group was simultaneously treated
with two deslorelin acetate 4.7 mg implants; the other group
was treated with a single deslorelin acetate 9.4 mg implant.
Egg production was decreased for approximately 14 weeks in
the group with two deslorelin acetate 4.7 mg implants. In
the group with one deslorelin acetate 9.4 mg implant, egg
production was decreased for at least 14 weeks but there was
a large variation between the birds (Petritz et al., 2015). In
another study with Japanese quail, seven out of nine hens
stopped laying eggs after the administration of a deslorelin acetate
implant, the majority of them for more than 14 weeks (Schmidt
et al., 2013). There is almost no knowledge about the effect of
deslorelin acetate implants in chicken. Noonan et al. (2012) tested
deslorelin acetate 4.7 mg and deslorelin acetate 9.4 mg in laying
hens (Gallus gallus). Two weeks after implantation, all treated
hens stopped laying eggs, regardless of the deslorelin acetate
concentration. Suppression of egg production lasted almost 26
weeks in hens treated with deslorelin acetate 4.7 mg and 45.5
weeks in hens treated with deslorelin acetate 9.4 mg (Noonan
et al., 2012). However, these results have to be interpreted with
care because the hens were already 2 years old when being
treated and the study was not published in a peer-reviewed
journal but as a scientific abstract. Thus, detailed information
about the study design and the analysis of the results is
lacking.
Based on the results of these studies, we chose to use
deslorelin acetate for the development of the desired animal
model with non-laying and laying control hens in the
current study. We tested whether a deslorelin acetate implant
could suppress egg production in hens if implanted before
or after the onset of lay. Furthermore, to characterize the
animal model, we assessed whether the implant would lead
to undesirable side effects and whether it would have any
influence on other traits such as body weight, organ weight,
general health, sexual hormone concentrations, and comb
size.
MATERIALS AND METHODS
Birds and Housing Conditions
The current experiment was performed in accordance with the
German Animal Protection Law and approved by the Lower
Saxony State Office for Consumer Protection and Food Safety
(No. 33.19-42502-04-15/1966).
A total of 40 Lohmann Selected Leghorn (LSL) hens (Gallus
gallus domesticus) were housed in two different age groups: one
group (“Adult”, 20 hens) was 21 weeks at the beginning of the
experiment whereas the other group (“Juvenile”, 20 hens) was 14
weeks old.
Table 1 details the age, management, and all experimental
procedures for both groups in each experimental week.
All birds were obtained from a conventional breeding
company (Zahrte, Wrestedt, Germany) at 14 weeks of age. In
the breeding company, the animals had been reared under
conventional conditions. After being brought to the experimental
site, birds were kept in a floor housing system. During the first
three experimental weeks, group “Adult” and group “Juvenile”
were kept in two pens within the same poultry house that were
separated by a solid wall. Each pen measured 11 m2, was littered
with wood-shavings and straw and equipped with perches and
a nest box measuring 0.54 m2. The light programs of both pens
were independent from each other. The duration of the light
period increased gradually from 10 h/day to 14 h/day. The 14 h
light period was reached in the 24th week of age (group “Ault”)
or in the 17th week of age (group “Juvenile”), respectively, and
kept constant until the end of the experiment. Since hens of group
“Juvenile” were exposed to 14 h light earlier than hens of group
“Adult”, the two age groups were analyzed separately (see section
Statistical Analysis). Light intensity was 20 lux at bird level.
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Group “Adult” (20 hens) Group “Juvenile” (20 hens)
Week of age Implant week Week of age Implant week
1 Arrival at experimental
site
21 −3 14 −1
2 B+E 22 −2 15 0
3 B+E 23 −1 16 1
4 Relocation B+E+U 24 0 17 2
5 B+E+U 25 1 18 3
6 B+E+U 26 2 19 4
7 B+E+U+R 27 3 20 5
8 B+E+U 28 4 21 6
9 B+E+U 29 5 22 7
10 B+E+U 30 6 23 8
11 B+E+U 31 7 24 9
12 B+E+U 32 8 25 10
13 B+E+U+CM 33 9 26 11
14 B+E+U+CM 34 10 27 12
15 B+E+U+CM+R 35 11 28 13
16 B+E+U+CM 36 12 29 14
17 B+E+U+CM 37 13 30 15
18 B+E+U+CM 38 14 31 16
19 B+E+U+CM 39 15 32 17
20 B+E+U+CM+D 40 16 33 18
B, blood withdrawal for analysis of estradiol-17ß concentrations; E, health examination; U, ultrasonography of ovaries; CM, comb size measurement; R, radiography of
keel bones; D, dissection; implant week 0, administration of deslorelin acetate implant; from this time point on, there were 10 treated and 10 control hens per group.
In experimental week 4, all hens were relocated to another
poultry house. Hens of both groups were housed in two pens
which were separated by a fence, resulting in both groups being
exposed to the same light program. Each pen measured 9 m2,
was littered with wood-shavings and straw and equipped with
perches and a nest box measuring 0.24 m2. The hens were offered
water and a conventional complete feed for pullets (until the 18th
week of age) and laying hens (from the 19th week of age on)
ad libitum.
Implantation of Deslorelin Acetate
Implants
Ten hens of each group were given a 4.7 mg deslorelin acetate
implant (Suprelorin R©, Virbac, Carros, France). In group “Adult”,
the implant was administered when all hens started laying (24th
week of age; Table 1), whereas in group “Juvenile”, the implant
was administered before the onset of lay (15th week of age;
Table 1). The remaining ten hens of each group were kept as
control hens within the same pen. The implant was administered
subcutaneously between the scapulae. Hens were anaesthetized
with 2–3% isoflurane (CP-Pharma Handelsgesellschaft mbH,
Burgdorf, Germany) in compressed air with a flow rate of
500 ml/min delivered via face mask. Before application, the skin
was aseptically prepared. After application, the implantation site
was sealed with a tissue adhesive (Surgibond R©, SMI, St. Vith,
Belgium). Control hens did not receive any treatment.
Weekly Health Examination of the Hens
The general health of all hens was checked daily and assessed
weekly (Table 1) and body weight was measured weekly.
Moreover, the implantation site was checked to confirm that
the implant was still present and to check for any signs of
inflammation or irritation. As some hens were observed to
develop foot pad dermatitis (FPD) over the course of the
experiment, special attention was paid to this disease and it
was noted down weekly whether a hen was affected or not.
Assessment of FPD was always performed by the same person
who was blinded to the treatment. Affected hens were treated
with antiseptics.
Ultrasonography of Ovaries
Each hen was examined via ultrasonography weekly (Table 1)
to check for ovarian follicles. The examination was conducted
with the ultrasound system DUS 60 vet and the microconvex
transducer C611-2 (both Edan Instruments GmbH, Shenzhen,
China). The transducer was placed on the area between the
vertebral column and the caudal rib (Figure 1). A frequency of
9.4 MHz was used and penetration depth varied between 39 and
58 mm. If present, follicles were visible as a round, anechoic zone
with a smaller, round, hyperechoic zone in the middle (Figure 2).
For each hen, the duration of effectiveness of the implant was
assessed based on the number of weeks in which no follicles were
detected by ultrasonography.
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FIGURE 1 | Area between the caudal rib and the dorsal column where the
transducer was placed.
FIGURE 2 | Sonogram of the ovary of a hen. The arrow marks an ovarian
follicle.
Egg Yolk Staining and Egg Collection
As an additional control of egg production, egg yolks of
treated and of control hens were stained in two different
colors, based on a method described by Appleby and McRae
(1983). Two different liposoluble dyes were used. Hens
treated with deslorelin acetate were given Sudan Black B;
control hens were given Oil Red O (both Sigma-Aldrich,
St. Louis, United States). The dyes were administered
weekly in gelatin capsules (Capsler, Stuhr, Germany) which
contained 30 mg sugar and 30 mg dye. The liposoluble
dye accumulates in the outer layer of all oocytes and can
be seen in the egg yolk from the 2nd to the 10th day after
administration.
Eggs were collected daily at 10 a.m. and cracked. The color of
each egg yolk was noted and each egg could be related to control
(red egg yolk) or treated hens (black egg yolk).
Measurement of Estradiol-17ß
Concentration in Plasma
Blood samples were taken weekly (Table 1) with twenty animals
(five treated and five control hens of both “Adult” and “Juvenile”)
being sampled each Tuesday, the remaining twenty animals each
Wednesday. All blood samples were taken between 8 and 11 a.m.
A maximum of 2 ml blood was taken from the ulnar vein.
Immediately after sampling, blood samples were centrifuged at
3500 rpm at 4◦C for 10 min. Plasma was stored at -20◦C until
further analysis.
Estradiol-17ß was measured in pg/ml using a commercial
enzyme-linked immunosorbent assay (ELISA) kit (IBL
International GmbH, Hamburg, Germany). A pool plasma
sample was included on each kit together with the individual
samples to calculate the inter-assay coefficient of variation which
was 0.18. Each blood sample was measured in duplicate to
calculate the intra-assay coefficient of variation. If the intra-assay
coefficient was higher than ten, the measurement was repeated.
Measurement of the Comb Size
From experimental week 13 on, the comb of each hen was
photographed weekly with a digital reflex camera (Table 1).
The hen was gently laid down on one side and the comb was
placed on a small box (13.5 cm × 13.5 cm × 3.5 cm) to ensure
it was plane. A ruler was placed beside the comb for scaling
purposes.
The same person blindly evaluated all comb photos, using the
image processing system AxioVision 4.8 (Carl Zeiss Microscopy
GmbH, Jena, Germany). For each photo, a scale was generated
using the ruler. Afterward, the outline of the comb was
circumscribed and the size of its surface area was calculated by
Axio Vision.
Radiographic Examination of the Keel
Bone
In order to detect any differences in keel bone damage between
the treatments, all hens were radiographed in experimental weeks
7 and 15 (Table 1).
Digital, lateral radiographs were taken and evaluated as
described previously (Eusemann et al., 2018) with 50.0 kV and
at 2 mAs. The evaluation of all images was performed blindly
by the same person and included the presence or absence of
fractures and the measurement of deviations. The latter was used
to calculate the proportion of deviated keel bone area (POD):
POD (%) = deviated area/keel bone surface area∗100.
Dissection
At the end of the experiment (experimental week 20), all
hens were euthanized. Hens were stunned electronically and
death was provoked by severing the jugular veins and carotid
arteries. The hens of group “Adult” were 40 weeks old
and the hens of group “Juvenile” were 33 weeks old at
the time point of euthanasia (Table 1). The ovary, oviduct,
heart, liver, spleen, intestine, gizzard, proventriculus, thyroid
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glands, lungs, kidneys, and brain were weighed and the
relative organ weights were calculated by dividing organ weight
by body weight. The length of the oviduct was measured.
Before weighing the ovary, all large follicles were removed.
Moreover, the implant was removed and the implantation site
was checked once again for any signs of inflammation or
irritation.
Statistical Analysis
Differences between treated and control hens were analyzed
separately for group “Adult” and group “Juvenile” due to different
light programs and different experimental time periods between
the groups. Data were analyzed using commercially available
software (SAS 9.3, SAS Institute Inc., 2011).
For statistical analysis of the binary variables “Presence of
follicles” and “Presence of FPD,” a linear logistic mixed model
for repeated measurements (Littel et al., 2006) was applied. An
analysis of covariance was performed for predicting the effect of
age on “Presence of follicles” or “Presence of FPD.” Regression
curves were fitted by considering age as a covariate term up
to degree 4 of polynomials and the fixed effect of treatment
(“treated” and “control”) as well as significant interactions
between the main factor treatment and the covariate (age) up
to degree 4 of polynomials. Least squares means were estimated
on the logit scale to fulfill model assumptions and then back-
transformed using the inverse link function to the original scale
(probability to have follicles or FPD, respectively). Post hoc
multiple comparisons of least squares means were performed
using Tukey’s test.
Data of the numerical variables “Estradiol-17ß concentration,”
“Body weight,” and “Comb size” were analyzed with a linear
mixed model using the same factors as above but with underlying
normal distribution. For analysis of estradiol-17ß concentrations,
the fixed effects of treatment and age up to degree 4 of
polynomials, their interaction up to degree 4 of polynomials,
and the pre-treatment estradiol-17ß plasma concentrations were
considered. For body weight development of the hens of group
“Juvenile”, the interaction between treatment and age was only
considered up to degree 2 of polynomials and for body weight
development of group “Adult”, a second-degree polynomial
was selected for the fixed regression term and the interaction
as only these effects were shown to be significant. Post hoc
multiple comparisons of least squares means were performed
using Tukey’s test.
For analysis of POD in both groups and at both time points of
data recording (experimental weeks 7 and 15), the fixed effect of
treatment, the time point and its interaction were considered in
the general linear model.
For statistical analysis of keel bone fractures, birds with one or
multiple fractures were scored as 1 and those without any fracture
as 0 at both time points. The effect of treatment on the binary
outcome variable “fracture” was analyzed by means of one Chi-
square test for each time point and group.
The relative weight to the body weight of the various organs
at the end of the experiment was analyzed using a general linear
model, considering only the fixed effect of the treatment in the
statistical model as described above.
RESULTS
General Health and Body Weight
No detectable adverse effects were found in any of the hens
treated with a deslorelin acetate implant. Neither were there any
signs of inflammation or irritation at the implantation site nor did
treated hens show any negative alterations in health or behavior
compared to control hens.
Group “Adult”
Control hens of group “Adult” were heavier compared to treated
hens throughout the experiment (treatment∗age: p < 0.0001;
Figure 3C).
Group “Juvenile”
In group “Juvenile”, no significant difference was found between
body weight of control and treated hens (p = 0.22; Figure 4C).
Follicles, Duration of Effectiveness, and
Egg Production
Group “Adult”
In group “Adult”, proportion of hens with follicles was
significantly higher in control compared to treated hens from
implant week 2 to implant week 13 (treatment∗age: p < 0.05;
Figure 3A). Follicles were detectable in all control hens from
implant week 1 onwards. Only in implant week 8, one control
hen did not show any detectable follicles. In all treated hens of
group “Adult”, follicles were detectable prior to implantation.
After implantation, the percentage of treated hens with follicles
decreased continuously and between implant week 5 and implant
week 10, none of the treated hens had follicles. From implant
week 11 onwards, 4/10 treated hens developed follicles again.
From implant week 14 onwards, treated and control hens of
group “Adult” did not differ significantly in proportion of hens
with follicles anymore (p > 0.05). The duration of effectiveness
of the deslorelin implant showed interindividual differences. The
shortest duration of effectiveness was 8 weeks in two treated hens
while it was at least 16 weeks in one of the hens remaining without
detectable follicles until the end of the experiment.
Group “Juvenile”
In none of the hens of group “Juvenile” follicles were detectable at
the beginning of the study (Figure 4A). In control hens, ovarian
follicles were first detected at implant week 6. Between implant
week 7 and the end of the experiment (implant week 18), ovarian
follicles were detectable in all control hens. 5/10 treated hens
developed follicles between implant week 9 and the end of the
study. The remaining five treated hens did not show follicles
throughout the study. In group “Juvenile”, treated and control
hens differed significantly in proportion of hens with follicles
until the end of the study (treatment∗age: p < 0.0001).
Egg Yolk Staining and Egg Collection
The results of egg yolk staining and egg collection confirmed
the findings of the ultrasonography in both groups (“Adult” and
“Juvenile”): The number of eggs laid by control or treated hens
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FIGURE 3 | Hens with follicles, estradiol-17ß concentrations, body weight and hens with foot pad dermatitis (FPD) of group “Adult”. (A) Proportion of control (blue
line) and treated hens (red line) with follicles on the ovary. (B) Least squares means (LSM; continuous lines) and upper and lower bounds of the 95% confidence
interval (dotted lines) of estradiol-17ß in plasma in control (blue) and treated hens (red). Missing overlap of lines indicates a significant difference (p < 0.05) between
groups. (C) LSM (continuous lines) and upper and lower bounds of the 95% confidence interval (dotted lines) of body weight of control (blue) and treated hens (red).
Missing overlap of lines indicates a significant difference (p < 0.01) between groups. (D) Proportion of hens with FPD of control (blue) and treated hens (red).
corresponded to the number of hens in which follicles were
detected via ultrasonography.
Estradiol-17ß Concentration in Plasma
Group “Adult”
Estradiol-17ß plasma concentration was significantly higher in
control compared to treated hens of group “Adult” from implant
week 2 until the end of the experiment (treatment∗age: p <
0.001; Figure 3B). Both treated and control hens started with a
high estradiol-17ß plasma concentration. While it remained at a
high level, reaching more than 500 pg/ml estradiol-17ß in control
hens, it decreased below 200 pg/ml in implant week 3 in treated
hens. By implant week 6, estradiol-17ß concentration started to
increase in treated hens but did not reach more than 300 pg/ml
until the end of the experiment (implant week 16). Pre-treatment
estradiol-17ß plasma concentrations did not affect estradiol-17ß
concentrations after implantation (p = 0.71).
Group “Juvenile”
Both treated and control hens of group “Juvenile” started with
a low concentration of estradiol-17ß (<100 pg/ml; Figure 4B).
The concentration increased throughout the experiment in all
hens. This increase in concentration was more pronounced and
started earlier in control compared to treated hens. Consequently,
higher concentrations of estradiol-17ß were found in control
hens compared to treated hens from implant week 1 until the
end of the experiment (treatment∗age: p < 0.01). Pre-treatment
estradiol-17ß plasma concentrations did not affect estradiol-17ß
concentrations after implantation (p = 0.75).
Comb Size
The comb was significantly larger in control compared to treated
hens in group “Adult” (LSM± SE: 26.7± 1.52 cm2 vs. 6.66± 1.52
cm2; p< 0.0001) as well as in group “Juvenile” (27.05± 1.52 cm2
vs. 7.23± 1.52 cm2; p < 0.0001).
Foot Pad Dermatitis
Group “Adult”
In group “Adult”, prevalence of FPD was significantly higher in
control compared to treated hens from implant week 6 until the
end of the experiment (treatment∗age: p < 0.01; Figure 3D). In
implant week 5, 1/10 control hens was affected by FPD and, at
Frontiers in Physiology | www.frontiersin.org 6 December 2018 | Volume 9 | Article 1846
fphys-09-01846 December 18, 2018 Time: 16:28 # 7
Eusemann et al. Deslorelin Acetate in Laying Hens
FIGURE 4 | Hens with follicles, estradiol-17ß concentrations, body weight and hens with FPD of group “Juvenile”. (A) Proportion of control (blue dashed line) and
treated hens (red dashed line) with follicles on the ovary. (B) LSM (dashed lines) and upper and lower bounds of the 95% confidence interval (dotted lines) of
estradiol-17ß in plasma in control (blue) and treated hens (red). Missing overlap of lines indicates a significant difference (p < 0.05) between groups. (C) LSM (dashed
lines) and upper and lower bounds of the 95 % confidence interval (dotted lines) of body weight of control (blue) and treated hens (red). Overlap of lines indicates no
significant difference (p > 0.05) between groups. (D) Proportion of hens with FPD of control (blue dashed line) and treated hens (red dashed line).
the end of the experiment, all ten control hens were affected. In
contrast, only 2/10 treated hens were affected by FPD throughout
the entire experimental period. One of these two treated hens
started laying eggs again 3 weeks prior to being affected by FPD.
Group “Juvenile”
In group “Juvenile”, prevalence of FPD was significantly higher in
control compared to treated hens from implant week 11 until the
end of the experiment (treatment∗age: p< 0.0001; Figure 4D). In
implant week 11, 1/10 control hens was affected by FPD and the
prevalence increased up to 7/10 control hens in implant weeks
16 and 17 before decreasing to 6/10 control hens in implant
week 18. In contrast, only 2/10 treated hens were affected by FPD
throughout the entire experimental period. Both of these two




In group “Adult”, POD significantly increased from experimental
week 7 (mean and standard error: 3.49 ± 0.5%) to experimental
week 15 (4.44 ± 0.4%; p < 0.01). Moreover, deviated keel bone
area was significantly larger in control (5.57 ± 0.6%) compared
to treated hens (2.36 ± 0.6%; p < 0.01). None of the hens had a
keel bone fracture in experimental week 7. In experimental week
15, the prevalence of keel bone fractures was significantly higher
in control (4/10 hens) compared to treated hens (0/10 hens; p <
0.05).
Group “Juvenile”
In group “Juvenile”, no significant influence on POD was found
for age (experimental week 7: 3.13 ± 0.53%, experimental week
15: 3.28 ± 0.4%; p = 0.76), treatment (control: 3.35 ± 0.57%,
treated: 3.06 ± 0.57%; p = 0.72) or their interaction (p = 0.12).
Similarly, no significant influence on prevalence of keel bone
fractures was found for treatment (experimental week 7: p = 1;
experimental week 15: p = 0.3). In experimental week 7, none of
the hens had a keel bone fracture and in experimental week 15,




In group “Adult”, the relative weight of the following organs was
significantly higher in control compared to treated hens (p <
0.01; Table 2): ovary, oviduct, liver, intestine, and kidneys. The
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TABLE 2 | Relative weight (% of body weight) of the organs of group “Adult” (left part) and group “Juvenile” (right part).
Group “Adult”: Relative organ
weight (% of body weight) (Least
squares means ± Standard Error)
P-value Group “Juvenile”: Relative organ
weight (% of body weight) (Least
squares means ± Standard Error)
P-value
Control hens Treated hens Control hens Treated hens
Ovary 0.66 ± 0.05 0.26 ± 0.05 < 0.0001 0.60 ± 0.07 0.38 ± 0.07 < 0.05
Oviduct 3.55 ± 0.34 1.18 ± 0.32 < 0.0001 3.43 ± 0.36 1.96 ± 0.38 < 0.05
Liver 2.42 ± 0.07 1.80 ± 0.08 < 0.0001 2.22 ± 0.12 1.76 ± 0.11 < 0.05
Spleen 0.10 ± 0.01 0.14 ± 0.01 < 0.05 0.11 ± 0.01 0.12 ± 0.01 0.26
Intestine 5.30 ± 0.14 4.73 ± 0.14 < 0.01 5.30 ± 0.23 4.67 ± 0.23 0.06
Gizzard 1.77 ± 0.10 1.59 ± 0.10 0.21 1.85 ± 0.09 1.51 ± 0.09 < 0.05
Proventriculus 0.36 ± 0.01 0.37 ± 0.01 0.6 0.37 ± 0.02 0.31 ± 0.02 < 0.01
Thyroid glands 0.07 ± 0.03 0.01 ± 0.03 0.17 0.01 ± 0.001 0.01 ± 0.001 0.61
Lungs 0.40 ± 0.02 0.40 ± 0.02 0.77 0.38 ± 0.01 0.35 ± 0.01 0.12
Kidneys 0.72 ± 0.02 0.59 ± 0.02 < 0.001 0.73 ± 0.03 0.54 ± 0.03 < 0.001
Brain 0.18 ± 0.01 0.19 ± 0.01 0.38 0.18 ± 0.01 0.18 ± 0.01 0.57
Heart 0.37 ± 0.02 0.33 ± 0.02 0.15 0.37 ± 0.02 0.28 ± 0.02 < 0.01
P < 0.05 represent a significant difference between the least squares means of treated and control hens within one group (“Adult” or “Juvenile”, respectively).
relative weight of the spleen, in contrast, was significantly higher
in treated compared to control hens (p < 0.05). No significant
difference (p> 0.05) was found in the relative weight of the heart,
gizzard, proventriculus, thyroid glands, lungs, and brain. The
oviduct was significantly longer in control compared to treated
hens (LSM± SE: 61.9± 3.7 cm vs. 37.9± 3.7 cm; p < 0.001).
Group “Juvenile”
In group “Juvenile”, the relative weight of the following organs
was significantly higher in control compared to treated hens
(p < 0.05; Table 2): ovary, oviduct, liver, gizzard, proventriculus,
kidneys, and heart. No significant difference (p> 0.05) was found
in the relative weight of the spleen, intestine (p < 0.1), thyroid
glands, lungs, and brain. The oviduct was significantly longer in
control compared to treated hens (LSM ± SE: 62.4 ± 5.1 cm vs.
39.4± 5.1 cm; p < 0.01).
DISCUSSION
With the current study we have successfully established an animal
model with non-laying and laying control hens which can be
used in further studies to investigate the relationship between egg
production and common diseases in laying hens as well as the
underlying mechanisms.
One deslorelin acetate 4.7 mg implant has been shown to
inhibit egg production both if implanted before and shortly after
the onset of lay. Based on the aim of the study in which this
animal model is intended to be used, researchers can decide
whether to apply the implant before or after the onset of lay.
In case of implantation after the onset of lay, laying hens have
already developed all reproductive functions and thus have the
same conditions as control hens. Implantation before the onset of
lay might ensure that treated hens never lay any eggs throughout
their lives. Further, this method can also be used to protract
the onset of lay to investigate the relationship between the early
onset of lay and different traits or diseases in laying hens. This
could especially be interesting for studies concerning keel bone
damage. Gebhardt-Henrich and Fröhlich (2015) found a negative
correlation between the age of hens when laying their first egg and
the probability of keel bone fracture presence at depopulation.
The keel bone ossifies at about 35 weeks of age (FAWC, 2010)
when laying hens have already been laying eggs for several weeks.
Therefore, ossification might be disturbed by the competing
demand for calcium to produce the egg shell, leading to a weak
keel bone.
A very important finding of the current study is the relatively
short duration of effectiveness of deslorelin acetate in laying
hens. In dogs, the species the implant has been developed for,
it is declared that Suprelorin R© 4.7 mg suppresses reproduction
for 6 months, i.e., 24 weeks. However, in group “Adult” of
the current study, the shortest duration of effectiveness was
only 8 weeks in two treated hens and at only 14 weeks after
implantation, treated and control hens did not differ significantly
anymore in proportion of hens with follicles. These findings
imply that when comparing non-laying and laying hens, implant
application would have to be repeated the latest 14 weeks after
initial implantation. However, these findings are not consistent
with the study by Noonan et al. (2012) in which the same implant
inhibited egg production for almost 26 weeks in laying hens.
However, hens in the study by Noonan et al. were older than the
hens in the present study which may explain this discrepancy.
Moreover, the use of different layer lines may also result in
different findings. However, we have no information which line
Noonan et al. used in their study since this study was not
published in a peer-reviewed journal, but as a scientific abstract
(Noonan et al., 2012). Duration of effectiveness of deslorelin
acetate, when implanted before the onset of lay, seemed to be
increased since a statistically significant difference in proportion
of hens with follicles between treated and control hens was
still present at the end of the experiment, i.e., 18 weeks after
implantation in group “Juvenile”. Due to different results between
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groups and studies and due to large interindividual differences
in duration of effectiveness, it seems to be impossible to give a
general recommendation concerning the interval after which a
new deslorelin acetate implant should be administered in laying
hens. In order to do so, long-term studies with hens of different
layer lines that are treated at different ages are required.
In accordance to findings by Noonan et al. (2012), the
deslorelin acetate implant was effective in all treated hens. In
Japanese quail, however, deslorelin acetate did not inhibit egg
production in some individuals (Petritz et al., 2013; Schmidt et al.,
2013). Even after administration of two 4.7 mg implants or one
9.4 mg implant, some of the treated quail continued to lay eggs
(Petritz et al., 2015). This indicates that the effect of deslorelin
acetate largely differs between species and thus, results from one
bird species cannot be readily transferred to another species.
In the current study, no placebo implant was given to control
hens. This is in contrast to other studies which investigated
the effect of sustained release deslorelin acetate implants on
reproduction in different species (Trigg et al., 2001; Petritz et al.,
2013, 2015; Schmidt et al., 2013; Summa et al., 2017). It is
therefore possible that different findings in treated compared to
control hens may be additionally due to the treatment procedure
itself and not due to deslorelin acetate alone. However, as our
results are very similar to results of studies with Japanese quail
in which placebo implants were used (Petritz et al., 2013, 2015;
Schmidt et al., 2013), it is more probable that differences were
caused by deslorelin acetate. Nevertheless, a study investigating
the effect of deslorelin acetate implants on egg production in
laying hens including control hens receiving a placebo implant
would help to strengthen our conclusions.
In both groups, “Adult” and “Juvenile”, no observable adverse
effects of the implant were found. The injection site was devoid
of signs of irritation or inflammation which indicates that the
use of the implant is safe in laying hens. This is consistent with
findings of other studies where deslorelin acetate implants were
proven to be safe in different bird species (Cook and Riggs, 2007;
Petritz et al., 2013). The only finding of the current study which
may point toward an adverse effect was the lower body weight
in treated compared to control hens of group “Adult”. However,
this may also be explained by the weight of an inactive oviduct
and ovary being much lower than the weight of an active oviduct
and ovary. The difference in weight of these two organs alone
is sufficient to explain the different body weight. Moreover, the
relative weight of the digestive tract, the liver, and the kidneys
was also higher in control compared to treated hens which may
be explained by an increased activity of these organs in control
hens, leading to the difference in body weight.
Some of our results on differences between treated and
control hens in other traits may facilitate the time point
determination of the implant’s effectiveness wearing off and
its need to be replaced. Control hens displayed larger combs
compared to treated hens. Thus, this characteristic may
facilitate a quick estimation whether a hen lays eggs or not.
Furthermore, estradiol-17ß plasma concentrations were lower
in treated compared to control hens. Hence, repeated hormone
concentration measurements may also serve as an indicator of
implant effectiveness. However, in order to ensure if a hen is
laying or not, ultrasonography of the ovary as well as egg yolk
staining can be applied.
The findings on lower estradiol-17ß plasma concentrations
in treated hens, which are in accordance with findings in other
species (ferrets: Wagner et al., 2005; Japanese quail: Petritz
et al., 2013), also have implications on further studies aiming at
comparing laying with non-laying hens. As estradiol-17ß has an
influence on several organs and mechanisms, it may be necessary
to substitute this hormone in an animal model with deslorelin
acetate depending on the hypothesis. For example, estradiol-17ß
plays an important role in bone metabolism and bone diseases
in laying hens as has been reviewed by Beck and Hansen (2004).
In order to investigate the influence of egg production on bone
health, it is therefore recommendable to substitute estradiol-17ß
at least in a subgroup of the treated hens in order to compare
laying and non-laying hens which have a similar estradiol-17ß
plasma concentration.
The decreased keel bone deviations and fractures in treated
compared to control hens of group “Adult” as well as the
incidental finding of decreased FPD prevalence in treated
compared to control hens of both groups indicate that egg
production may be related to these diseases. Concerning keel
bone damage, our findings in group “Adult” support the
hypothesis that the high demand for calcium to produce the egg
shell leads to weaker bones. In contrast, we did not find any
differences between treated and control hens in group “Juvenile”.
This may be explained by the relatively young age in which
these hens were radiographed (20th and 28th week of age). Keel
bone damage has been shown to increase with age (Käppeli
et al., 2011a; Heerkens et al., 2016; Eusemann et al., 2018).
Consequently, we may have detected differences between control
( = laying) and treated ( = non-laying) juvenile hens later in life,
i.e., if we had kept and radiographed the hens at later ages. In
order to gain more insight into the etiology of keel bone fractures
and deviations and the role of egg production, a study comparing
keel bones of laying and non-laying hens throughout the entire
laying period would be required. Concerning FPD, almost all
affected hens were control hens or treated hens which had started
laying eggs again. This finding suggests that non-laying hens may
display a more active immune system which is in accordance
with the higher relative weight of the spleen, an important organ
of the immune system, in treated compared to control hens.
Differences in the immune system between laying and non-laying
hens could be explained by different plasma concentrations
of estradiol-17ß and possibly other gonadal steroids as these
have been shown to regulate the immune system (reviewed by
Grossman, 1985). However, to fully understand this incidental
finding, the relationship between egg production, estradiol-17ß
plasma concentrations, FPD, and the immune system needs to be
investigated in more detail.
CONCLUSION
We present a valid animal model with non-laying and laying
control hens which can be used to investigate the relationship
between egg production and different diseases in laying hens.
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This model has been achieved by administration of one 4.7 mg
deslorelin acetate implant per hen. However, based on our results,
duration of effectiveness in laying hens seems to be much shorter
than previously reported.
Furthermore, we have shown differences between treated and
control hens in other traits such as comb size and estradiol-
17ß concentrations. Lastly, our findings indicate that keel bone
fractures and deviations as well as FPD may be related to egg
production in laying hens.
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